Published in Am J Respir Cell Mol Biol on December 01, 1991
Cytokines and pulmonary fibrosis. Thorax (1993) 1.13
New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax (1992) 1.01
Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.00
Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts. Acta Pharmacol Sin (2010) 0.77
Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages. Am J Respir Cell Mol Biol (1991) 1.36
Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. Am J Respir Cell Mol Biol (1991) 1.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature (1986) 2.94
Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med (1983) 2.71
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest (1983) 2.27
Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis (1984) 2.17
Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med (1986) 1.90
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages. J Clin Invest (1986) 1.80
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res (1994) 1.69
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest (1984) 1.68
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest (1984) 1.61
Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol (1996) 1.60
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis (1987) 1.57
Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol (1992) 1.56
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med (1983) 1.38
Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.36
Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest (1993) 1.34
Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) (1989) 1.22
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis (1985) 1.20
Translational control of the antiapoptotic function of Ras. J Biol Chem (2000) 1.19
The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest (1997) 1.19
Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest (1991) 1.13
Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis (1984) 1.11
Unusual forms of pulmonary embolism. Clin Chest Med (1994) 1.10
Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation. J Immunol (1986) 1.05
Is there a fibrotic gene? Chest (1980) 1.04
Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med (1994) 1.04
Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest (1989) 1.03
Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. Am J Respir Crit Care Med (1999) 0.97
Lovastatin induces apoptosis in malignant mesothelioma cells. Am J Respir Crit Care Med (1998) 0.95
Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer (2009) 0.95
Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. Ann Intern Med (1987) 0.95
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor. Am Rev Respir Dis (1984) 0.93
Inhibition of mesothelioma cell growth in vitro by doxycycline. J Lab Clin Med (2001) 0.91
Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall. Chest (1983) 0.89
Safety of bronchoalveolar lavage in the critically ill, mechanically ventilated patient. Crit Care Med (1991) 0.88
KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT. Am J Physiol Lung Cell Mol Physiol (2000) 0.87
Mechanisms of alveolar fibrosis after acute lung injury. Clin Chest Med (1990) 0.84
A comparison of Guatemalan and USA nurses' attitudes towards nursing. Int Nurs Rev (2004) 0.84
The role of ceroid in lung and gastrointestinal disease in Hermansky-Pudlak syndrome. Adv Exp Med Biol (1989) 0.84
Alveolar epithelial cells regulate the induction of endothelial cell apoptosis. Am J Physiol (1994) 0.83
Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype. Cancer Gene Ther (2012) 0.82
Repair after acute lung injury. Chest (1994) 0.81
Environmental lung disease and the interstitium. Clin Chest Med (1981) 0.80
The lung matrix and inflammation: Part II. Biochemical and molecular mechanisms of fibrogenesis: implications for environmental lung disease. Am Rev Respir Dis (1988) 0.78
Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders. Am Rev Respir Dis (1988) 0.78
Single lung transplantation for severe emphysema. J Heart Lung Transplant (1992) 0.78
Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report. J Neurosurg (1995) 0.78
Pulmonary oxygen toxicity. Bronchoalveolar lavage demonstration of early parameters of alveolitis. Chest (1983) 0.77
Failure of lung repair following acute lung injury. Regulation of the fibroproliferative response (Part 1). Chest (1990) 0.77
Cell fusion to study nuclear-cytoplasmic interactions in endothelial cell apoptosis. Am J Pathol (1996) 0.77
Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents. Br J Cancer (1978) 0.76
Cell cycle controls in higher eukaryotic cells: resting state or a prolonged G1 period? J Theor Biol (1986) 0.76
Onset of DNA replication in nuclei of proliferating and resting NIH 3T3 fibroblasts following fusion. Exp Cell Res (1983) 0.76
Failure of lung repair following acute lung injury. Regulation of the fibroproliferative response (Part 2). Chest (1990) 0.75
Tracheobronchial obstruction due to silicosis. Am Rev Respir Dis (1992) 0.75
Glomerular disease and lung transplantation. Am J Kidney Dis (1995) 0.75
Low-frequency positive-pressure ventilation with extracorporeal carbon dioxide removal. Crit Care Med (1990) 0.75
Cellular hypertrophy and hyperplasia in disorders of the pulmonary circulation. Am Rev Respir Dis (1989) 0.75
Current concepts of the pathogenesis of fibrosis: lessons from pulmonary fibrosis. Prog Clin Biol Res (1984) 0.75
Cellular rest as an active metabolic state. Prog Clin Biol Res (1982) 0.75
Reactivation of rat peritoneal leukocyte and mast cell nuclei in heterokaryons with actively growing mouse cells. Cell Differ (1981) 0.75
Acute lung injury. A transgenic murine model of intra-alveolar fibrosis. Chest (1994) 0.75
Combined laser phototherapy and growth factor treatment of bronchial obstruction after lung transplantation. Chest (1991) 0.75